CPA Webinar: Developing Expertise in Cognitive Behavioral Therapy for lnsomnia (CBT-l)
Friday, April 23, 2021, 9:00 AM - 4:00 PM MDT
Category: Webinar
Regular Registration (Now through April 16) Late Registration (April 17 through April 22) REGISTER HERE
Insomnia, which is highly prevalent in adults as a primary or co-morbid disorder, is significantly more prevalent as a consequence of Covid-19. CBT-I is now considered the first-line treatment for insomnia. It improves sleep in 75% of patients, is more effective than sleeping pills, and reduces or eliminates sleeping pills in the vast majority of patients. It also doubles the remission rates of depression compared to antidepressant medication alone in depressed patients with insomnia, and it improves numerous comorbid medical and psychological symptoms (including PTSD and chronic pain). As a result, insomnia is now considered an independent disorder that should be treated separately from co-morbid conditions. Although CBT-I is now considered the first-line treatment for insomnia due to its superior long-term efficacy, lack of side effects, and patient preference, there is a shortage of clinicians with expertise in CBT-I. This six-hour remote training will enable clinicians to develop competence in CBT-I using an empirically and clinically validated CBT-I protocol. It is based on three decades of research and clinical practice at Harvard Medical School and the University of Massachusetts Memorial Medical Center and a landmark federally-funded study conducted at Harvard Medical School by Gregg D. Jacobs, Ph.D. and colleagues demonstrating that the same CBT-I protocol was more effective than Ambien for insomnia (Jacobs, GD, et al. Cognitive Behavior Therapy and Pharmacotherapy for Insomnia: A Randomized Controlled Trial and Direct Comparison. Archives of Internal Medicine, 2004, 164: 1888-96). Agenda (times are in Mountain Time): 9:00AM - 10:30AM: Program CEs: 6.0 CEs Learning Objectives: After attending this webinar, attendees will be able to: 1. Describe the empirical support for CBT-I.
Speaker:
Dr. Gregg D. Jacobs is a sleep psychologist who researched and treated insomnia for 30 years at the Harvard and University of Massachusetts Medical Schools where his insomnia research was funded by the National Institutes of Health. He has taught his insomnia program to over 10,000 patients, to HMOs such as Kaiser Permanente and Fortune 500 companies such as Reebok, Fidelity, and John Hancock, and his insomnia program has been used by major insurers such as Blue Cross and Blue Shield and Fortune 500 companies such as Raytheon.
Dr. Jacobs is the author of Say Good Night to Insomnia (New York: Henry Holt, 2009) which has been translated into eight languages.
|